---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-22-017017"
form_type: "8-K"
ticker: "LIXT"
cik: "0001335105"
company_name: "LIXTE BIOTECHNOLOGY HOLDINGS, INC."
filed_at: "2022-06-17T23:59:59+00:00"
generated_at: "2026-06-25T00:46:38.944034+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Lixte Biotechnology appoints Dr. René Bernards as independent director

## Summary
- Dr. René Bernards appointed to board; he is a leader in molecular carcinogenesis at Netherlands Cancer Institute.
- Co-founded four biotech companies; member of Royal Netherlands Academy of Sciences, AACR Fellow.
- Presented new data at AACR on effectiveness of lead compound LB-100 with various anti-cancer agents.
- Compensation: one-time $100k cash fee and annual $40k payable quarterly in lieu of stock options.

## SEC filing metadata
- accession: 0001493152-22-017017
- form_type: 8-K
- ticker: LIXT
- cik: 0001335105
- company_name: LIXTE BIOTECHNOLOGY HOLDINGS, INC.
- filed_at: 2022-06-17T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1335105/000149315222017017/0001493152-22-017017-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1335105/000149315222017017/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-22-017017
- JSON: https://secwatch.observer/filing/0001493152-22-017017.json
- Plain text: https://secwatch.observer/filing/0001493152-22-017017.txt

## Key facts
- Executive change
  Dr. René Bernards was appointed as director at LIXTE BIOTECHNOLOGY HOLDINGS, INC..
  - Action: appointed
  - Role: director
  source text: Effective as of June 15, 2022, the Company’s Board of Directors (the “Board”) appointed Dr. René Bernards to the Board as an independent director.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1335105/000149315222017017/0001493152-22-017017-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.